Clinical Trials Browser

Phase 3 × belzutifan × 90 days × Clear all

NCT07227402 2026-04-17

LITESPARK-033

Phase 3 Recruiting

Carcinoma, Carcinoma, Renal Cell

NCT07405164 2026-04-17

MK-6482-043

Phase 3 Recruiting

Carcinoma, Renal Cell, von Hippel-Lindau Disease

NCT07489495 2026-03-24

LITESPARK-034

Phase 3 Not yet recruiting

Carcinoma, Renal Cell

NCT04586231 2026-03-05

MK-6482-011

Phase 3 Active not recruiting

Carcinoma, Renal Cell